🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

.ESGE recommends #Cellvizio for enhancing pancreatic cyst diagnosis, advancing its commercial adoption. A major step towards improving diagnostic accuracy and reducing unnecessary surgeries for patients worldwide! hubs.la/Q039bqj_0 #GITwitter #pancreaticcysts

Prof. Jost Langhorst, MD, of Bamberg Clinic in Germany was recently interviewed about the #CellTolerance program, designed to provide clarity for patients with #IBS symptoms while creating personalized solutions. hubs.la/Q039GLBl0 #foodintolerance #GItwitter

Finding the cause of patients' #IBS symptoms is challenging. Prof. Jost Langhorst, MD shared insights into his clinical studies yielding groundbreaking results that are changing the way we approach patient care. hubs.la/Q03bjDQ50 #CellTolerance #GITwitter

#ICYMI 🎉#Cellvizio is now recommended in the latest ESGE guidelines for characterizing pancreatic cystic lesions! 🔍Learn more: maunakeatech.com/news/cellvizio… #PancreaticCysts #GITwitter

During #ColorectalCancerAwarenessMonth, take a moment to learn how Cellvizio aids in the management of colorectal neoplasia for real-time polyp characterization and guided treatment: hubs.la/Q03bt93v0 #ScreeningSavesLives Colorectal Cancer Alliance

What is the typical experience patients have with the #CellTolerance test? Prof. Jost Langhorst, MD of Bamberg Clinic in Germany provides a walkthrough of the test process at the video below. hubs.la/Q03bLD7r0 #ibs #foodintolerance #GITwitter #guthealth

Pr. Jost Langhorst, MD is shedding light on the biggest challenges #IBS patients face, especially when it comes to getting diagnosed with #foodintolerance. Want to learn more about #CellTolerance? Check out the full interview: hubs.la/Q03chNfy0 #GITwitter #GutHealth

Without answers, patients can struggle for years with an undiagnosed, #IBS-related #foodintolerance. Pr. Jost Langhorst, MD discloses how frequently he encounters these patients & what their typical journey looks like. Visit: hubs.la/Q03cJcJK0 #CellTolerance #GITwitter

Existing tests & elimination diets often fall short, leaving #IBS patients frustrated without a clear pathway to quality of life. In this clip, Pr. Jost Langhorst, MD provides an explanation & to view the full interview visit: hubs.la/Q03dhQHN0. #CellTolerance #GITwitter

France's #MedTech scene is buzzing!🇫🇷Our founder, Sacha Loiseau 🎗️ & Stéphane Regnault make the argument for medical innovations being crucial to tackling healthcare challenges like aging population, chronic diseases, & staff shortages. linkedin.com/posts/mauna-ke…

Witnessing #IBS patients struggle without relief, led Pr. Jost Langhorst, MD, a #foodintolerance expert, to join the #CellTolerance program! This program helps those frustrated with traditional diagnostics & are ready for finding pleasure in food. Again. hubs.la/Q03dGgsf0

Advancement in early #esophagealcancer detection could significantly impact global health outcomes! A new study demonstrates how #Cellvizio is empowering #AI deep learning models to detect with incredible accuracy. Learn more: hubs.la/Q03fqWrs0 #EarlyDetection #GITwitter

Celebrating #WorldHealthDay, we acknowledge the power of innovation in shaping global health. As a global medical device company, we're driven to develop technologies for early intervention & lasting well-being, ensuring a healthier future for all. World Health Organization (WHO) #SeeCellsChangeLives

BE is the only known precursor of EAC, thus adequate surveillance EGD procedures are vital to avoid the progression to more serious disease states. During #EsophagealCancerAwarenessMonth, discover the power of an early & accurate diagnosis with #Cellvizio: hubs.la/Q03gNfcm0

Humbled & honored to receive - Innovation in Science 🏆 from The National Pancreas Foundation. Grateful to mentors, colleagues, industry collaborators. 🏆for our patients The James Erica Park Raj Shah Daryl C. Donatelli Nick LaPrairie Jordan Burlen, MD Georgios Papachristou Eric Swei Tessa Crilley Alec Latta

Article in Press: "Interobserver agreement in dysplasia grading of intraductal papillary mucinous neoplasms" by Leupold et al. giejournal.org/article/S0016-… Somashekar Krishna, MD, MPH Wei Chen Ashwini Kumar Esnakula Ahmed Abdelbaki Zarine Shah Erica Park Jordan Burlen, MD Hamza Shah Georgios Papachristou

Millions or 12% of the US suffer from disruptive #IBS symptoms. This #IBSAwarenessMonth, help patients find relief & empower them to reclaim their digestive health with #CellTolerance, a program that visualizes cell responses to identify food triggers. hubs.la/Q03hwJ5b0

Decoding #IBS & #foodintolerances is complex! A team of dietitians & gastroenterologists is key to understanding & treating these issues. Learn why by watching the #CellTolerance Masterclass with nutrition expert Beth Rosen MS RD CDN (she/her). hubs.la/Q03hXFYD0 #IBSAwarenessMonth #guthealth

Learn about diagnosing food intolerances in #IBS patients during #WorldIBSDay2025. Discover the importance of this diagnosis via the real-time assessment of intestinal barrier dysfunction with #Cellvizio advanced imaging. hubs.la/Q03j0MyQ0 #IBSAwarenessMonth #GITwitter

Frustrated by the diagnostic ambiguity of food intolerances in #IBS patients? Assoc. Prof. Dr. Johann Hammer from MedUni Wien shares how direct assessment of gut barrier responses to food enables personalized management strategies through #CellTolerance. hubs.la/Q03jxbJ60